Suven Life Sciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sources of funds

Owner's fund

Equity share capital

21.81

21.81

14.54

12.73

12.73

Share application money

-

-

-

36.92

-

Preference share capital

-

-

-

-

-

Reserves & surplus

823.57

831.64

461.44

352.01

374.95

Loan funds

Secured loans

-

-

0.48

0.39

1.08

Unsecured loans

-

-

-

-

-

Total

845.38

853.44

476.46

402.05

388.76

Uses of funds

Fixed assets

Gross block

77.46

88.53

82.53

66.93

43.61

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

49.25

51.32

44.97

45.97

18.92

Net block

28.21

37.21

37.56

20.96

24.69

Capital work-in-progress

-

-

3.55

4.77

-

Investments

653.05

528.20

425.85

295.11

241.86

Net current assets

Current assets, loans & advances

170.23

295.03

19.38

94.54

143.20

Less : current liabilities & provisions

6.11

7.00

9.89

13.34

21.00

Total net current assets

164.12

288.04

9.49

81.20

122.20

Miscellaneous expenses not written

-

-

-

-

-

Total

845.38

853.44

476.46

402.05

388.76

Notes:

Book value of unquoted investments

653.05

528.20

425.85

295.11

241.86

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

2180.74

2180.74

1453.82

1272.82

1272.82